Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative diseases that occur either in relatively rare, familial forms or in common, sporadic forms. The genetic defects underlying several monogenic familial forms of AD and PD have recently been identified, however, the causes of other AD and PD cases, particularly sporadic cases, remain unclear. To gain insights into the pathogenic mechanisms involved in AD and PD, we used a proteomic approach to identify proteins with altered expression levels and/or oxidative modifications in idiopathic AD and PD brains. Here, we report that the protein level of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), a neuronal de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial PD, is down-regulated in idiopathic PD as well as AD brains. By using a combination of two-dimensional gel electrophoresis and mass spectrometry, we have identified three human brain UCH-L1 isoforms, a full-length form and two amino-terminally truncated forms. Our proteomic analyses reveal that the full-length UCH-L1 is a major target of oxidative damage in AD and PD brains, which is extensively modified by carbonyl formation, methionine oxidation, and cysteine oxidation. Furthermore, immunohistochemical studies show that prominent UCH-L1 immunostaining is associated with neurofibrillary tangles and that the level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains. Together, these results provide evidence supporting a direct link between oxidative damage to the neuronal ubiquitination/de-ubiquitination machinery and the pathogenesis of sporadic AD and PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dysfunction contributes to neuronal damage and death by several mechanisms, including ER stress and the accumulation of oxidatively damaged proteins, which in the normal brain are usually degraded by the UPS and autophagy to keep their levels low8,50,53,55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“a crucial part of the UPS is oxidatively damaged and dysfunctional in both aMCI and AD brain, namely, ubiquitin carboxyl-terminal hydrolase L-1 (UCH L1)34,55–57.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“the failure of oxidatively damaged UCH L1 to perform its function in aMCI and AD brains leads to accumulation of ubiquitinylated proteins, decreased proteasome function, and subsequent accumulation of damaged, aggregated proteins55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Roepstorff, P., & Fohlman, J. (1984) · Biological Mass Spectrometry · doi:10.1002/bms.1200111109 · Cited by 2,633
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Methionine residues as endogenous antioxidants in proteins
Levine, R. L., Mosoni, L., Berlett, B. S., & Stadtman, E. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15036 · Cited by 1,041
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Research works printed but not linked: 2
- Ischiropoulos, 2003, J. Clin. Invest., 111, 163, 10.1172/jci200317638 · DOI · Paper page
- Wu, 1996, Alzheimer's Res., 2, 163
Cited by
Items 501–571 of 571
Sultana, R., Reed, T. T., & Butterfield, D. A. (2008) · Wiley eBooks · doi:10.1002/9783527622467.ch9 · Cited by 2
Immunotherapies for Movement Disorders: Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Schutt, C. R., Gendelman, H. E., & Mosley, R. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_46 · Cited by 2
Loss of UCHL1 Leads to Enhanced Mouse Osteoclast Formation
Chiba, M., Hoshikawa, S., Shimizu, K., Fujita, H., Wada, K., Yamada, A., Saito, K., Inuzuka, H., & Fukumoto, S. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70032 · Cited by 1
“UCHL1 is regarded as a neuronal marker that accounts for about 1% – 5% of total soluble proteins in the brain, and pathologically, UCHL1 deposition with ubiquitin is found in Lewy bodies in the neuronal cells (Choi et al. 2004; Maraganore et al. 2004; Wilkinson et al. 1989; Xia 2008).”
Tayama, Y., Kawahara, H., Minami, R., Shimada, M., & Yokosawa, H. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9553-z · Cited by 1
“Several ubiquitin-processing enzymes have also been suggested to be involved in Alzheimer’s disease [17, 18].”
BackgroundControl of Autophagy in Parkinson’s Disease
González‐Polo, R. A., Gómez‐Sánchez, R., Pizarro‐Estrella, E., Yakhine-Diop, S. M. S., Rodríguez‐Arribas, M., & Fuentes, J. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_6 · Cited by 1
Nakamura, T., & Lipton, S. A. (2009) · doi:10.1201/9781420073522-11 · Cited by 1
Çetin, İ., Bulut, H., & Şimşek, Ş. (2017) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2016-0291 · Cited by 2
“Previous studies also found widespread impairments including interference control, deficits expressed-inattention, hyperactivity, and behavioural inhibition in patients with ADHD [3, 18, 35, 36].”
Single-Cell Transcriptome Analysis in Tumor Tissues
Iwabuchi, S., & Hashimoto, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84558 · Cited by 2
Бурлев, В. А., & Ilyasova, N. A. (2023) · Russian Journal of Human Reproduction · doi:10.17116/repro2023290119 · Cited by 1
Nwabufo, C. K. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10215-4 · Cited by 1
“The mRNA and protein expression levels of UCHL1 were reduced in the brains of idiopathic PD patients (Choi et al. 2004; Barrachina et al. 2006).”
Ubiquitin C-terminal Hydrolase-L1
Eletr, Z. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00459-2 · Cited by 1
Brain Oxidative Stress in the Pathogenesis and Progression of Alzheimer’s Disease
Sultana, R., Swomley, A. M., & Butterfield, D. A. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_8 · Cited by 1
Crichton, R. R., & Ward, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118553480.ch06 · Cited by 1
Mass Spectrometry Approaches for the Redox Characterization of Protein Cysteine Residues
Scaloni, A., & Tell, G. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)73012-3 · Cited by 1
Sixt, S., Jennissen, H. P., Winterhalter, M., & Laub, M. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-10-428 · Cited by 1
RetractedSultana, R., Poon, H. F., & Butterfield, D. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_15 · Cited by 1
“Others recently confirmed the oxidative modification of UCH L-1 in AD brain using proteomics [ 57 ].”
BackgroundMethodNeurotropic Viruses: Trojan for Complex Neurodegenerative Diseases?
(2015) · Journal of Neuroinfectious Diseases · doi:10.4172/2314-7326.1000173
Dukes, A. A. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
Rajagopal, M. U. (2006) · UKnowledge (University of Kentucky)
Regulation of internalization and replication of intracellular bacterial pathogens
Bassères, E. (2011) · Figshare
Mrozik, K. M., Xiong, J., Zilm, P. S., Gronthos, S., & Bartold, P. M. (2011) · Springer eBooks · doi:10.1007/978-94-007-2828-8_24
Nakamura, T., & Lipton, S. A. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch2
Buesa, C. (2012) · Treballs de la Societat Catalana de Biologia
Bernstein, A. I., & O’Malley, K. L. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_11
“Oxidative modification of other proteins, including proteins linked to familial PD, such as DJ-1, UCH-L1, and parkin has also been identified in PD brains [6–8].”
BackgroundThe role of alpha synuclein in Parkinson’s disease
Moualla, D. (2011) · The University of Bath Online Publications Store (The University of Bath) · Cited by 1
Proteomics of mouse cortex following conditional deletion of Psmc1 proteasomal subunit in neurones
Elkharaz, J. (2013) · Nottingham ePrints (University of Nottingham)
The impact of developmental stress on the functioning and vulnerability of CNS neurons
Pienaar, I. S. (2008) · SUNScholar (Stellenbosch University)
Mutant Superoxide Dismutase-1-caused pathogenesis in Amyotrophic Lateral Sclerosis
Bergemalm, D. (2010) · DiVA at Umeå University (Umeå University) · Cited by 1
Yang, W. (2006) · OakTrust (Texas A&M University Libraries)
polymorphisms have synergic effect on the risk of Parkinson's disease among Taiwanese
Wu, Y., Chen, C., Chen, Y., Chao, C., Ro, L. S., Fung, H., Hsiao, Y.-C., Hu, F.-J., & Lee‐Chen, G. (2010)
Proteasomal Degradation of Soluble, Misfolded Proteins
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00003-1
Roles of Multiple Types of Autophagy in Neurodegenerative Diseases
Kabuta, T., Fujiwara, Y., & Wada, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405530-8.00004-2 · Cited by 1
Nakamura, T., Hansen, M., Oldham, S., & Lipton, S. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6231-8.10025-x
The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease
Chopra, N. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c28019
Carbonylated Proteins and Their Metabolic Regulation
Afiuni‐Zadeh, S., & Griffin, T. J. (2017) · Wiley eBooks · doi:10.1002/9781119374947.ch6
Oxidative Stress and Redox Signalling in the Parkinson’s Disease Brain
Hernández-Franco, P., Anandhan, A., Foguth, R. M., & Franco, R. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00027
Powis, R. A. (2016) · Edinburgh Research Archive (University of Edinburgh)
Shen, Y., Zhao, Z., You, N., Ju, R., & Pan, Z. (2018) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000246
Crystal structures of two alanylpiperidine analogues
Mambourg, K., Tumanov, N. A., Henon, G., Lanners, S., Garcia-Ladona, J., & Wouters, J. (2021) · Acta Crystallographica Section E Crystallographic Communications · doi:10.1107/s2056989021010392
Kikuchi, T. (2021) · AIMS molecular science · doi:10.3934/molsci.2021024
Lipton, S. A., & Nakamura, T. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch6
Sultana, R., & Butterfield, D. A. (2007) · Wiley eBooks · doi:10.1002/9783527622153.ch23
The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease
Garza-Lombó, C., & Franco, R. (2022) · Molecular and integrative toxicology · doi:10.1007/978-3-030-87451-3_4 · Cited by 1
Mrozik, K. M., Xiong, J., Zilm, P. S., Gronthos, S., & Bartold, P. M. (2011) · Springer eBooks · doi:10.1007/978-94-007-2415-0_8
Ding, L., Chu, W., Xia, Y., Ming, S., Li, T., Zhou, F., & Deng, D. Y. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461600 · Cited by 1
“For instance, the protein level of UCHL1 is inversely associated with the number of neurofibrillary tangles in AD brains (Choi et al., 2004); the overexpression of it resulted in decreased level of phosphorylated tau, while its knockdown led to increased formation of phosphorylated tau (Cartier et…”
BackgroundMózes, E. (2021) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10783
Biochemical and Genetic Markers in Neurological Trauma and Tumors: Review Article
Ashraf, O., Saleem, T. H., Elsadek, B., Hamdan, A. R. K., & Hassan, M. H. (2022) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2022/v11i230260
“Increased amounts of UCHL1 in neuroblastomas were associated to being well-differentiated, which according to Gu and his colleagues, can be considered as a sign of favorable prognosis [36].”
Ding, L., Chu, W., Xia, Y., Ming, S., Li, T., Luo, L., Zhou, F., & Deng, D. Y. B. (2022) · Research Square · doi:10.21203/rs.3.rs-2320747/v1
Proteomic-Based Studies on Memory Formation in Normal and Neurodegenerative Disease-Affected Brains
Beraldo, I. J. S., Rodrigues, M. P., Polanczyk, R. S., Verano‐Braga, T., & Lopes‐Aguiar, C. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-50624-6_7
Analysis of UBE3A induced ubiquitination and its role in regulating prefrontal cortex excitability
Alduntzin, U. (2022) · theses.fr (ABES) · doi:10.70675/815be038zab60z4d74z8b54z7175585e5abb
Data Mining and Biochemical Profiling Reveal Novel Biomarker Candidates in Alzheimer’s Disease
Vernone, A., Stura, I., Guiot, C., D’Agata, F., & Silvagno, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157536
A new variant in the UCHL1 gene supporting its implication in late-onset ataxia with optic atrophy
Gioiosa, V., Marcotulli, C., Degoutin, M., Angelini, C., Goizet, C., Tessa, A., Santorelli, F. M., & Casali, C. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08657-y
Ageing of neural stem cells in a Parkinson's disease Model
Menzl, I. (2013) · University of Vienna · doi:10.25365/thesis.27046
Mazo, C. (2024) · Deep Blue (University of Michigan) · doi:10.7302/23782
Paciotti, S., Wojdała, A. L., Bellomo, G., Toja, A., Chipi, E., Piersma, S. R., Pham, T. V., Gaetani, L., Jiménez, C. R., Parnetti, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23691223
Xu, L., Li, M., Wei, A., Yang, M., Li, C., Liu, R., Zheng, Y., Chen, Y., Wang, Z., Wang, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21275870
Issa, S. A.-R. (2015) · theses.fr (ABES) · doi:10.70675/bac47709za653z4723z85f6z620ca3c186e3 · Cited by 1
Étude du métabolisme des protéines carbamylées intracellulaires
Desmons, A. (2018) · theses.fr (ABES) · doi:10.70675/3d2300c4z5a71z4329z96dazf2cff1c7ad95
Menacho-Román, M., Rodríguez, A. M., Alonso, J. R. P., Heras, I. P. D. L., Bártulos, A. V., & Arribas-Gómez, I. (2026) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfag110
Wan, T., Wang, X. J., Mei, X., & Guo, S. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118278
The Emerging Role of UCHL1 in Neurological and Musculoskeletal Diseases
Feng, R., Zhong, X., Li, J., & Achuthan, A. A. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70151
“Extensive oxidative modification of its critical cysteine residues severely compromises both its protein solubility and its catalytic activity [39, 40].”
Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity
Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Jallow, O., Sheyn, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202600020
Tripathi, S. J., Chakraborty, S., Wood, N. B., Hoopes, D., Barker, S., Vázquez‐Rosa, E., An, J., Ma, C., Hou, Y., Sharma, S. M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2606205123
Arayesh, M. J., Ataellahi, F., & Masoudi, R. (2026) · Gene · doi:10.1016/j.gene.2026.150431
Shi, X., Chen, G., Wang, X., Ma, R., & Li, G. (2026) · Biomolecules · doi:10.3390/biom16101494
“UCH-L1 colocalizes with NFTs in AD brains, and soluble UCH-L1 levels are inversely correlated with NFT burden, suggesting a potential association with tau pathology [38,39].”
Vellingiri, B., Balasubramani, K., Karuppusamy, P. A., Uvarajan, D., Muneeshwaran, N. S., Lakhanpal, V., Muthukumar, S., Elangovan, A., Babu, H. W. S., Yadav, M. K., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102548
Oxidation sensitivity of deubiquitylases as amplifiers of brain aging
Sahu, A. K., Galvagni, F., Busch, K. E., Ori, A., & Pfirrmann, T. (2026) · Trends Open · doi:10.1016/j.treopn.2026.09.018
Newman, S. F. (2009) · UKnowledge (University of Kentucky)
Metadata
- Authors
- Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Li, Lian
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 13256-13264
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2169393803
- Cited by
- 568
- References
- 38
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 20 · 2021: 36 · 2020: 16 · 2019: 16 · 2018: 22 · 2017: 28 · 2016: 24 · 2015: 26 · 2014: 34 · 2013: 29 · 2012: 30
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG010130, AG-10130, AG021489, R01AG021489)
- National Cancer Institute (P30CA054174, CA-54174)
- National Institute of Neurological Disorders and Stroke (NS-047199, R01NS047199)
- National Institute of Environmental Health Sciences (ES-12068, U54ES012068)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- UCHL1, Parkinson's disease, Alzheimer's disease, protein oxidation, carbonylation, methionine oxidation, cysteine oxidation, deubiquitination, neurofibrillary tangles, protein downregulation, brain proteome
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Brain, Chromatography, High Pressure Liquid, Coloring Agents, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Molecular Sequence Data, Mutation, Oxygen, Parkinson Disease, Mass Spectrometry, Trypsin, Immunoblotting, Electrophoresis, Gel, Two-Dimensional, Down-Regulation, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Oxidative Stress, Protein Isoforms, Proteome, Ubiquitin Thiolesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.